Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...

Regionally, North America leads, followed by Europe, with fast growth in Asia-Pacific. Challenges include high costs, surgery ...

A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...

But the vagus nerve can also be stimulated via the skin, usually in or around the left ear, using small electrical pulses ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Evidence from a new large UK multicentre trial is challenging the results from a previous smaller US trial that led to the ...

Please provide your email address to receive an email when new articles are posted on . Patients in the active treatment group saw a 37.4% reduction in wrinkle severity from baseline. They also saw a ...

Pulsetto is emerging as a notable development within the expanding field of non-invasive wellness technology, particularly in the area of nervous system regulation. As global attention continues to ...

Pulsetto is emerging as a notable development within the expanding field of non-invasive wellness technology, particularly in the area of nervous system regulation. As global attention continues to ...